| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $38.2M | -0.2% |
| Cost of Revenue | $25.0M | -10.7% |
| Gross Profit | $13.2M | +28.1% |
| R&D Expense | $330K | +108.5% |
| SG&A Expense | $218K | +12.3% |
| Operating Income | $5.5M | +83.9% |
| Pre-tax Income | $5.0M | +36.7% |
| Income Tax | $851K | +741.3% |
| Net Income | $3.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.6M | +52.1% |
| Short-term Investments | $2.4M | -10.8% |
| Accounts Receivable | $11.7M | +18.8% |
| Inventory | $10.9M | -2.2% |
| Current Assets | $34.6M | +14.4% |
| Total Assets | $60.0M | +8.1% |
| Current Liabilities | $11.9M | +18.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.6M | -20.3% |
| Capital Expenditures | $5.0M | -0.5% |
| Investing Cash Flow | -$2.5M | +56.7% |
| Financing Cash Flow | -$978K | -123.4% |
| Free Cash Flow | $604K | -69.8% |
| +9.5% |
| EPS (Basic) | $0.24 | +9.1% |
| EPS (Diluted) | $0.24 | +9.1% |
| Long-term Debt |
| $8.8M |
| +7.9% |
| Total Liabilities | $18.6M | +8.1% |
| Stockholders' Equity | $38.0M | +8.0% |